Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.

Jiyong Liang, Joyce M Slingerland

Research output: Contribution to journalArticle

665 Citations (Scopus)

Abstract

As its role in tumor progression emerges, the PI3K/PKB (Akt) pathway presents an appealing cancer therapeutic target. Recent studies have investigated the mechanisms underlying the tumor-promoting effects of this pathway. PKB triggers a network that positively regulates G1/S cell cycle progression through inactivation of GSK3-beta, leading to increased cyclin D1, and inhibition of Forkhead family transcription factors and the tumor suppressor tuberin (TSC2), leading to reduction of p27Kip1. The identification of p21Waf1/Cip1 and p27Kip1 as novel substrates of PKB provided new insights into mechanisms whereby hyperactivation of this lipid signaling pathway may lead to cell cycle deregulation in human cancers. The PI3K pathway may also play a key role in the G2/M transition and its constitutive activation may lead to defects in DNA damage checkpoint control.

Original languageEnglish
Pages (from-to)339-345
Number of pages7
JournalCell cycle (Georgetown, Tex.)
Volume2
Issue number4
StatePublished - Jul 1 2003
Externally publishedYes

Fingerprint

Phosphatidylinositol 3-Kinases
Tumors
Cell Cycle
Cells
Neoplasms
Deregulation
Cyclin D1
Forkhead Transcription Factors
Transcription Factors
Chemical activation
Lipids
Defects
DNA
DNA Damage
Substrates
Therapeutics

ASJC Scopus subject areas

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Cite this

Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. / Liang, Jiyong; Slingerland, Joyce M.

In: Cell cycle (Georgetown, Tex.), Vol. 2, No. 4, 01.07.2003, p. 339-345.

Research output: Contribution to journalArticle

@article{643ac746c042411aaec1d7b276063ab1,
title = "Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.",
abstract = "As its role in tumor progression emerges, the PI3K/PKB (Akt) pathway presents an appealing cancer therapeutic target. Recent studies have investigated the mechanisms underlying the tumor-promoting effects of this pathway. PKB triggers a network that positively regulates G1/S cell cycle progression through inactivation of GSK3-beta, leading to increased cyclin D1, and inhibition of Forkhead family transcription factors and the tumor suppressor tuberin (TSC2), leading to reduction of p27Kip1. The identification of p21Waf1/Cip1 and p27Kip1 as novel substrates of PKB provided new insights into mechanisms whereby hyperactivation of this lipid signaling pathway may lead to cell cycle deregulation in human cancers. The PI3K pathway may also play a key role in the G2/M transition and its constitutive activation may lead to defects in DNA damage checkpoint control.",
author = "Jiyong Liang and Slingerland, {Joyce M}",
year = "2003",
month = "7",
day = "1",
language = "English",
volume = "2",
pages = "339--345",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.

AU - Liang, Jiyong

AU - Slingerland, Joyce M

PY - 2003/7/1

Y1 - 2003/7/1

N2 - As its role in tumor progression emerges, the PI3K/PKB (Akt) pathway presents an appealing cancer therapeutic target. Recent studies have investigated the mechanisms underlying the tumor-promoting effects of this pathway. PKB triggers a network that positively regulates G1/S cell cycle progression through inactivation of GSK3-beta, leading to increased cyclin D1, and inhibition of Forkhead family transcription factors and the tumor suppressor tuberin (TSC2), leading to reduction of p27Kip1. The identification of p21Waf1/Cip1 and p27Kip1 as novel substrates of PKB provided new insights into mechanisms whereby hyperactivation of this lipid signaling pathway may lead to cell cycle deregulation in human cancers. The PI3K pathway may also play a key role in the G2/M transition and its constitutive activation may lead to defects in DNA damage checkpoint control.

AB - As its role in tumor progression emerges, the PI3K/PKB (Akt) pathway presents an appealing cancer therapeutic target. Recent studies have investigated the mechanisms underlying the tumor-promoting effects of this pathway. PKB triggers a network that positively regulates G1/S cell cycle progression through inactivation of GSK3-beta, leading to increased cyclin D1, and inhibition of Forkhead family transcription factors and the tumor suppressor tuberin (TSC2), leading to reduction of p27Kip1. The identification of p21Waf1/Cip1 and p27Kip1 as novel substrates of PKB provided new insights into mechanisms whereby hyperactivation of this lipid signaling pathway may lead to cell cycle deregulation in human cancers. The PI3K pathway may also play a key role in the G2/M transition and its constitutive activation may lead to defects in DNA damage checkpoint control.

UR - http://www.scopus.com/inward/record.url?scp=2342618936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342618936&partnerID=8YFLogxK

M3 - Article

C2 - 12851486

AN - SCOPUS:2342618936

VL - 2

SP - 339

EP - 345

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 4

ER -